| Direct Competitor Comparison | |
|---|
| ARIA | NVS | PFE | PVT1 | Industry |
|---|
| Market Cap: | 3.07B | 182.23B | 203.58B | N/A | 71.76B |
|---|
| Employees: | 300 | 129,000 | 89,400 | 6401 | 450.00 |
|---|
| Qtrly Rev Growth (yoy): | 78.80 | 0.02 | -0.09 | N/A | 0.27 |
|---|
| Revenue (ttm):
| 6.94M | 57.80B | 57.60B | 182.70M1 | 13.93B |
|---|
| Gross Margin (ttm): | -0.41 | 0.68 | 0.81 | N/A | 0.72 |
|---|
| EBITDA (ttm): | -221.82M | 17.15B | 25.34B | N/A | 1.51B |
|---|
| Operating Margin (ttm):
| -32.39 | 0.22 | 0.32 | N/A | 0.13 |
|---|
| Net Income (ttm): | -229.65M | 9.66B | 10.52B | 8.70M1 | N/A |
|---|
| EPS (ttm): | -1.36 | 3.94 | 2.09 | N/A | 0.61 |
|---|
| P/E (ttm): | N/A | 18.82 | 13.74 | N/A | 18.43 |
|---|
| PEG (5 yr expected): | -1.08 | 2.76 | 4.75 | N/A | 1.51 |
|---|
| P/S (ttm): | 442.23 | 3.15 | 3.53 | N/A | 3.64 |
|---|
|
| NVS = Novartis AG | | PFE = Pfizer Inc. | | Pvt1 = Zeltia, S.A. | | Industry = Biotechnology | | 1 = As of 2012 |
| Biotechnology Companies Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Amgen Inc. | AMGN | 102.18 | 0.00 | 76.63B | 17.30 |
|---|
| Genentech, Inc. | Private |
|---|
| Biogen Idec Inc. | BIIB | 225.18 | 0.00 | 53.45B | 35.73 |
|---|
| Genzyme Corporation | Private |
|---|
| Merck Serono S.A. | Private |
|---|
| Gilead Sciences Inc. | GILD | 55.74 | 0.00 | 85.02B | 31.21 |
|---|
| MedImmune, L.L.C. | Private |
|---|
| Life Technologies Corporation | LIFE | 73.57 | 0.00 | 12.66B | 31.15 |
|---|
| Teva Pharmaceutical Industries Limited | TEVA | 40.19 | 0.00 | 34.24B | 20.06 |
|---|
| Sandoz International GmbH | Private |
|---|
|
| Generic Drugmakers Ranked by Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Actavis, Inc. | ACT | 127.15 | 0.00 | 16.24B | N/A |
|---|
| Ranbaxy Laboratories Limited | Private |
|---|
| Mylan, Inc. | MYL | 31.28 | 0.00 | 11.92B | 20.90 |
|---|
| Pfizer Inc. | PFE | 28.70 | 0.00 | 203.58B | 13.74 |
|---|
| Johnson & Johnson | JNJ | 88.01 | 0.00 | 247.21B | 23.90 |
|---|
| GlaxoSmithKline plc | GSK | 52.21 | 0.00 | 126.45B | 19.08 |
|---|
| Sanofi | SNY | 53.84 | 0.00 | 142.50B | 26.54 |
|---|
| Novartis AG | NVS | 74.16 | 0.00 | 182.23B | 18.82 |
|---|
| Roche Holding AG | RHHBY | 63.53 | 0.00 | 215.61B | 21.26 |
|---|
| AstraZeneca PLC | AZN | 51.50 | 0.00 | 64.38B | 11.39 |
|---|
|
| Drugmakers Ranked By Sales | |
|---|
|
| Company | Symbol | Price | Change | Market Cap | P/E |
|---|
| Abbott Laboratories | ABT | 37.81 | 0.00 | 58.94B | 11.52 |
|---|
| Bristol-Myers Squibb Company | BMY | 43.76 | 0.00 | 71.88B | 49.56 |
|---|
|
| News on Direct Competitors | |
|---|
Currency in USD. | |
|
0.30%